Literature DB >> 6233394

Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion.

M Simonovic, G A Gudelsky, H Y Meltzer.   

Abstract

8-OH- DPAT (8-hydroxy-2-[di-n-propylamino] tetralin) is a novel aminotetralin derivative which has been proposed to be a serotonin (5-HT) agonist devoid of dopamine agonist effects. We now report that the administration of 8-OH- DPAT , like known 5-HT agonists, produced a rapid elevation of serum prolactin concentrations in male rats. The prolactin response to 8-OH- DPAT , like that induced by other 5-HT agonists, was greatly potentiated in animals pretreated with the tryptophan hydroxylase inhibitor, para-chlorophenylalanine. However, the 8-OH- DPAT -induced elevation of serum prolactin concentrations in untreated rats was not dose-dependent and was modest in magnitude compared to that produced by known 5-HT agonists. In contrast to the stimulatory effects of 8-OH- DPAT on prolactin secretion in vivo 8-OH- DPAT suppressed the secretion of prolactin from anterior pituitary tissue in vitro, and this effect was blocked by haloperidol. The results of the present study are supportive of the view that 8-OH- DPAT has dopamine agonist, as well as 5-HT agonist, properties.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233394     DOI: 10.1007/bf01255412

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  13 in total

1.  Synthesis and pharmacology of some 2-aminotetralins. Dopamine receptor agonists.

Authors:  J D McDermed; G M McKenzie; A P Phillips
Journal:  J Med Chem       Date:  1975-04       Impact factor: 7.446

2.  Effect of quipazine on rat plasma prolactin levels.

Authors:  H Y Meltzer; V S Fang; S M Paul; R Kaluskar
Journal:  Life Sci       Date:  1976-10-01       Impact factor: 5.037

3.  Synthesis and dopaminergic activity of (+/-)-, (+)-, and (-)-2-dipropylamino-5-hydroxy-1,2,3,4-tetrahydronaphthalene.

Authors:  J D McDermed; G M McKenzie; H S Freeman
Journal:  J Med Chem       Date:  1976-04       Impact factor: 7.446

4.  On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat.

Authors:  L Krulich; E Vijayan; R J Coppings; A Giachetti; S M McCann; M A Mayfield
Journal:  Endocrinology       Date:  1979-07       Impact factor: 4.736

5.  8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site.

Authors:  D N Middlemiss; J R Fozard
Journal:  Eur J Pharmacol       Date:  1983-05-20       Impact factor: 4.432

6.  Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats.

Authors:  A Quattrone; G Schettini; G di Renzo; G Tedeschi; P Preziosi
Journal:  Brain Res       Date:  1979-09-28       Impact factor: 3.252

7.  N-Alkylated 2-aminotetralins: central dopamine-receptor stimulating activity.

Authors:  U Hacksell; U Svensson; J L Nilsson; S Hjorth; A Carlsson; H Wikström; P Lindenberg; D Sanchez
Journal:  J Med Chem       Date:  1979-12       Impact factor: 7.446

8.  Effect of buspirone on rat plasma prolactin levels and striatal dopamine turnover.

Authors:  H Y Meltzer; M Simonovic; V S Fang; G A Gudelsky
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

9.  Pharmacological evidence that serotonergic stimulation of prolactin secretion is mediated via the dorsal raphe nucleus.

Authors:  L D Van de Kar; C L Bethea
Journal:  Neuroendocrinology       Date:  1982-10       Impact factor: 4.914

10.  Stimulation of rat prolactin secretion by indolealkylamine hallucinogens.

Authors:  H Y Meltzer; R G Fessler; M Simonovic; V S Fang
Journal:  Psychopharmacology (Berl)       Date:  1978-04-11       Impact factor: 4.530

View more
  11 in total

1.  Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat.

Authors:  S Ahlenius; V Hillegaart; A Wijkström
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

2.  Proceedings of the British Pharmacological Society Meeting. 3rd-5th January 1990. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

3.  Proceedings of the British Pharmacological Society Meeting. Sheffield, 18-20th April 1990.

Authors: 
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

4.  The effects of gepirone on neuroendocrine function and temperature in humans.

Authors:  I M Anderson; P J Cowen; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Neuroendocrine response to clonidine and 8-OH-DPAT in rats following chronic administration of desipramine or sertraline.

Authors:  J M O'Donnell; M Grealy
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

6.  Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man.

Authors:  H Y Meltzer; M Maes
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

7.  NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors.

Authors:  H Nissbrandt; G Engberg; H Wikström; T Magnusson; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

8.  5-HT1A agonists and dopamine: the effects of 8-OH-DPAT and buspirone on brain-stimulation reward.

Authors:  A M Montgomery; I C Rose; L J Herberg
Journal:  J Neural Transm Gen Sect       Date:  1991

9.  Gonadotropin and prolactin secretion in prepubertal female rats treated with 8-hydroxy-2-(di-n-propylamino) tetralin.

Authors:  E Aguilar; A Ranchal; R Aguilar; L Pinilla
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  Effects of 5-HT1A agonists and 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT-dopamine interaction.

Authors:  J M Liebman; S C Gerhardt; R Gerber
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.